When should I follow up after sending a proposal?

On the date you both named. If you didn't name one, five business days is fair for most mid-market deals. Enterprise legal reviews can take longer, so ask what their review path looks like instead of guessing. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

How do I get a sales VP to take a meeting?

Show a leak they recognize: slow follow-up, weak stage conversion, messy handoffs. Ask for a short look at that one number. Don't pitch a philosophy of selling. They already have one, and their forecast is louder than your sequence. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What subject line works for Pharmaceuticals proposal follow-up emails (after an invoice)?

Name the situation and the business object, not your excitement. Something like "[Company Name] / time through MLR" outperforms "Just checking in" because a sales VP can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

How many times should I follow up with a Sales VP (after an invoice)?

Wait until the review window you agreed on. If none was set, five business days. A polite reminder a few days after due, then a firmer operational note. After that, send a breakup note and archive it. A sales VP who wants it will answer a clean close more often than a fifth bump.

Should I lower the price in the follow-up?

Not as an opening move. Ask what's blocking the decision first. If budget is the issue, trim scope or phase the work. Discounting before you know the objection trains them to wait you out. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · Sales VP · After Invoice

Proposal Follow-Up for Pharmaceuticals Sales VP: After Invo…

Use this proposal follow-up template when you're emailing a Sales VP in Pharmaceuticals (after an invoice). Money is on the table. The relationship is real. Your job is to make payment simple and keep dignity on both sides. Keep the note aligned with Crisp and commercial. They can handle a direct ask.

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this proposal follow-up work for a Pharmaceuticals Sales VP?

Offer a smaller package so budget isn't a binary wall.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
Restate number, due date, invoice ID, and pay path in the first screen.
Give them a clean no so they don't ghost out of politeness.

When should I send this to a Pharmaceuticals Sales VP?

Wait until the review window you agreed on. If none was set, five business days. A polite reminder a few days after due, then a firmer operational note. For this combo, treat "3 days after due date" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome. Tuesday through Thursday mid-morning local time is a safe default.

What this Sales VP actually cares about

A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. If you cannot name a label update, a launch window, or a congress, wait until you can. If you cannot name a label update, a launch window, or a congress, wait until you can.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone crisp and commercial.
If legal is involved, ask for their redline format now.
Time it for 3 days after due date. A polite reminder a few days after due, then a firmer operational note.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after invoice note?

Asking 'any thoughts?' after a 12-page proposal invites silence.
Don't threaten, guilt, or bury the amount.
Don't use consumer-startup slang. It's a credibility leak.
Telling them how to sell. They've heard it.

How does this after invoice scenario compare?

Dimension	For this template
Best send window	3 days after due date
Ideal length	70 to 90 words. Lead with the outcome.
Primary ask	a 15-minute look at one metric, not a platform tour
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Crisp and commercial. They can handle a direct ask.
Unlike proposal follow-up	The commercial terms were already accepted. You're in collections-lite, not sales.
Unlike apology	Only apologize if you invoiced wrong. Don't apologize for asking to be paid.

What should I copy and send?

Copy-ready template

Subject

[Company Name] / time through MLR

Body

Hi [First Name],

Before this sits in a pile, I can cut [option] or split the rollout.

In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. If [competitor path] is still in play, I can send a one-page comparison on [criteria they named].

Get paid or learn the blocker: PO, coding, approval, or dispute.

Which piece is actually blocking a yes or no?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Lead with time through MLR, access, and compliant engagement rates. That's the language this buyer already reports. If you can't connect your email to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick, you're asking them to do the translation work. They won't.

Related templates

Want a custom draft instead? Try the email generator.